Masayoshi Koinuma
Overview
Explore the profile of Masayoshi Koinuma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki M, Hasegawa Y, Tanabe H, Koinuma M, Funakoshi R
J Pharm Health Care Sci
. 2024 Jul;
10(1):38.
PMID: 38997775
Background: Perioperative management of patients on dialysis is critical for controlling bleeding and thrombotic risk, in addition to infection control. Postoperative anticoagulation is often difficult to control, and different institutions...
2.
Higashihara M, Pavey N, Menon P, van den Bos M, Shibuya K, Kuwabara S, et al.
Eur J Neurol
. 2024 Mar;
31(7):e16281.
PMID: 38504632
Background And Purpose: Cortical hyperexcitability has been identified as a diagnostic and pathogenic biomarker of amyotrophic lateral sclerosis (ALS). Cortical excitability is assessed by transcranial magnetic stimulation (TMS), a non-invasive...
3.
Kamimura T, Kobayashi Y, Tamaki S, Koinuma M
J Am Med Dir Assoc
. 2024 Mar;
25(8):104961.
PMID: 38428834
Objectives: This study aimed to examine the impact of prefracture cognitive impairment (CI) severity and postoperative delirium on recovery after hip fracture surgery in older patients. Design: Prospective study with...
4.
Yoshifuji A, Toda M, Ryuzaki M, Oyama E, Kikuchi K, Kawai T, et al.
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992238
Humoral and cellular responses are critical in understanding immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Here, we evaluated these responses in hemodialysis (HD) patients after the...
5.
Oiwa A, Hiwatashi D, Takeda T, Miyamoto T, Kawata I, Koinuma M, et al.
J Clin Endocrinol Metab
. 2023 Mar;
108(9):2203-2210.
PMID: 36916985
Context: Although adding spironolactone to renin-angiotensin system blockers reduces albuminuria in adults with chronic kidney disease and type 2 diabetes, it increases the risk of hyperkalemia. Objective: To assess whether...
6.
Koike S, Shimizu K, Ide S, Mishima S, Matsuoka S, Takeda T, et al.
Thorac Cancer
. 2022 Oct;
13(21):3018-3024.
PMID: 36193574
Background: Consolidation tumor ratio (CTR) calculated as the ratio of the tumor consolidation diameter to the tumor maximum diameter on thin-section computed tomography (CT) of lung cancer has been reported...
7.
Yoshifuji A, Toda M, Ryuzaki M, Kikuchi K, Kawai T, Sakai K, et al.
Ren Replace Ther
. 2022 Aug;
8(1):39.
PMID: 35999867
Background: Dialysis patients are predisposed to severe disease and have a high mortality rate in coronavirus disease 2019 (COVID-19) due to their comorbidities and immunocompromised conditions. Therefore, dialysis patients should...
8.
Toda M, Yoshifuji A, Kikuchi K, Koinuma M, Komatsu M, Fujii K, et al.
Clin Exp Nephrol
. 2022 Mar;
26(6):581-582.
PMID: 35262832
No abstract available.
9.
Toda M, Yoshifuji A, Kikuchi K, Koinuma M, Komatsu M, Fujii K, et al.
Clin Exp Nephrol
. 2022 Feb;
26(6):571-580.
PMID: 35133533
Background: The mortality rate of Coronavirus disease 2019 (COVID-19) is extremely high in hemodialysis patients (HDP). These patients also develop lower antibody titers after vaccination. Therefore, factors associated with antibody...
10.
Araki Y, Momo K, Yasu T, Ono K, Uchikura T, Koinuma M, et al.
Sci Rep
. 2021 Nov;
11(1):22701.
PMID: 34811462
Antimicrobial resistance is a major health concern. A primary cause is the inappropriate use of antimicrobials, particularly by patients with upper respiratory tract infection. However, baseline information for antibiotic use...